QSC Tirzepatide is a novel GLP-1 (glucagon-like peptide-1) receptor agonist with enhanced pharmacological properties. This peptide compound demonstrates superior stability and prolonged biological activity compared to first-generation GLP-1 analogs.
The molecular structure of QSC tirzepatide incorporates strategic modifications that significantly extend its half-life while maintaining potent GLP-1 receptor activation. These characteristics make it particularly valuable for metabolic research applications.
Our QSC tirzepatide is produced under strict quality control standards, ensuring consistent purity and performance for research purposes. The product is supplied as a lyophilized powder in sterile vials for laboratory use only.
Important Note: This product is intended for research applications only. Not for human consumption or diagnostic use. Proper laboratory safety protocols should always be followed when handling this material.